This site is powered by the ProTrainings platform. All content is © 2026, ProTrainings Europe Ltd. All rights reserved.
Pro Trainings is rated 4.6 out of 5 based on 70450 ratings.
Skin cancer trial results ‘exciting’
Both treatments, for advanced melanoma, are designed to enable the immune system to recognise and target tumours. The findings were released at the American Society of Clinical Oncology conference in Chicago. The experimental drugs, pembrolizumab and nivolumab, block the biological…